Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

Delayed Quote. Delayed  - 07/22 10:01:55 pm
106.25 USD   -0.01%
07/21EDWARDS LIFESCI : half-yearly earnings release
07/15 EDWARDS LIFESCI : To Host Earnings Conference Call On July 26, 2016
07/13 EDWARDS LIFESCI : To Host Earnings Conference Call On July 26, 2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
07/21EDWARDS LIFESCIENCES CORP : half-yearly earnings release
07/20 EDWARDS LIFESCIENCES : Assigned Patent
07/16 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Ju..
07/15 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On July 26, 2016
07/14 EDWARDS LIFESCIENCES : Trademark Application for "DATASPHERE" Filed by Edwards L..
07/13 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On July 26, 2016
07/11 MEDTRONIC : Global Plaque and Thrombus Management Devices Market 2016 - Abbott, ..
07/08 Medtech's 2016 stock surge confronts second-quarter test
07/07 EDWARDS LIFESCIENCES : Trademark Application for "CARPENTIER-EDWARDS PHYSIO II" ..
07/06 EDWARDS LIFESCIENCES : Assigned Patent
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth
07/19DJINTUITIVE SURGICAL : Tops Expectations
07/19DJINTUITIVE SURGICAL : Tops Expectations
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/20 Abiomed Is Expensive - Cramer's Lightning Round (7/19/16)
07/15 Stocks Are Not Overvalued - Cramer's Mad Money (7/14/16)
07/06 Sun Comes Out For Big-Cap Medtechs As Investors Seek Refuge From Market Squal..
07/01 Brexit Isn't The Biggest Concern, It's Inflation And Deflation's Double-Edged..
06/21 Johnson & Johnson, Part II - Falling Behind On Medical Devices
Advertisement
Financials ($)
Sales 2016 2 889 M
EBIT 2016 791 M
Net income 2016 588 M
Finance 2016 562 M
Yield 2016 -
P/E ratio 2016 38,98
P/E ratio 2017 32,71
EV / Sales 2016 7,59x
EV / Sales 2017 6,74x
Capitalization 22 500 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 117 $
Spread / Average Target 10,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
John T. Cardis Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..34.53%22 500
THERMO FISHER SCIENTIF..10.60%61 738
BOSTON SCIENTIFIC CORP..29.72%32 456
INTUITIVE SURGICAL, IN..26.22%26 536
PHILIPS0.96%24 759
ILLUMINA, INC.-21.46%22 192
More Results